Enhanced 11beta-hydroxysteroid dehydrogenase activity, the metabolic syndrome, and systemic hypertension.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Cardiology

• Publication date

  2006-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2006.03.028PMID 16893715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.

  2005cited by this paper
• In vivo activity of 11β‐hydroxysteroid dehydrogenase type 1 and free fatty acid‐induced insulin resistance

  2005cited by this paper
• Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity.

  2005cited by this paper
• Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats.

  2005cited by this paper
• Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone.

  2005cited by this paper
• Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.

  2004cited by this paper
• Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins.

  2004cited by this paper
• 11β-Hydroxysteroid dehydrogenase Type 1 activity in lean and obese males with Type 2 diabetes mellitus

  2004cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.

  2004cited by this paper
• Regulation of 11β‐HSD Genes in Human Adipose Tissue: Influence of Central Obesity and Weight Loss

  2004cited by this paper
• Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.

  2004cited by this paper
• Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.

  2004cited by this paper
• Associations between a polymorphism in the 11 beta hydroxysteroid dehydrogenase type I gene and body composition

  2003cited by this paper
• Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians.

  2003cited by this paper
• Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity.

  2003cited by this paper
• Aldosterone: its receptor, target genes, and actions.

  2003cited by this paper
• The Natural History of the Development of Obesity in a Cohort of Young U.S. Adults between 1981 and 1998

  2002cited by this paper
• Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

  2002cited by this paper
• Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue Is Not Increased in Human Obesity

  2002cited by this paper
• Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.

  2002cited by this paper
• Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.

  2002cited by this paper
• A Transgenic Model of Visceral Obesity and the Metabolic Syndrome

  2001cited by this paper
• Metabolic conversion as a pre-receptor control mechanism for lipophilic hormones.

  2001cited by this paper
• Tissue-specific dysregulation of cortisol metabolism in human obesity.

  2001cited by this paper
• Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats.

  2000cited by this paper
• Understanding the Role of Glucocorticoids in Obesity: Tissue-Specific Alterations of Corticosterone Metabolism in Obese Zucker Rats1.

  2000cited by this paper
• Understanding the role of glucocorticoids in obesity

  2000cited by this paper
• An in vivo study of the cortisol–cortisone shuttle in subcutaneous abdominal adipose tissue

  1999cited by this paper
• 11 beta-Hydroxysteroid dehydrogenase.

  1999cited by this paper
• Differentiation of Adipose Stromal Cells: The Roles of Glucocorticoids and 11β-Hydroxysteroid Dehydrogenase.

  1999cited by this paper
• Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase.

  1999cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.

  1997cited by this paper
• 11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

  1997cited by this paper
• Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man

  1996cited by this paper
• Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity.

  1995cited by this paper
• Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation.

  1995cited by this paper
• Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension.

  1995cited by this paper
• Identification and expression cloning of a leptin receptor, OB-R.

  1995cited by this paper
• Evidence of Coexisting Changes in 11β-Hydroxysteroid Dehydrogenase and 5β-Reductase Activity in Subjects With Untreated Essential Hypertension

  1995cited by this paper
• The effects of cortisol on the regulation of lipoprotein lipase activity in human adipose tissue.

  1994cited by this paper
• Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes.

  1994cited by this paper
• Deficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertension

  1993cited by this paper
• Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor.

  1988cited by this paper
• Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.

  1987cited by this paper
• Effects of glucocorticoids on carbohydrate metabolism.

  1976cited by this paper
• Letter: Secure units for mentally ill.

  1975cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Cortisol Metabolism in Human Obesity: Impaired Cortisone3Cortisol Conversion in Subjects with Central Adiposity*

  year unknowncited by this paper
• 0013-7227/02/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 87(6):2701–2705 Printed in U.S.A. Copyright © 2002 by The Endocrine Society Expression of the mRNA Coding for 11�-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue from Obese Pat

  year unknowncited by this paper

• 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases

  2022cites this paper
• A urinary metabolomics study of a Polish subpopulation environmentally exposed to arsenic.

  2019cites this paper
• A new cryptic host defense peptide identified in human 11-hydroxysteroid dehydrogenase-1 β-like: from in silico identification to experimental evidence.

  2017cites this paper
• Crytic antimicrobial peptides hidden in protein precursors: identification of novel bioactive molecules

  2017influential citation
• Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists

  2016cites this paper
• Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients.

  2014cites this paper
• Obesity Pharmacotherapy: Current Perspectives and Future Directions

  2013cites this paper
• High-end normal adrenocorticotropic hormone and cortisol levels are associated with specific cardiovascular risk factors in pediatric obesity: a cross-sectional study

  2013cites this paper
• The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.

  2012cites this paper
• Dietary fructose, salt absorption and hypertension in metabolic syndrome: towards a new paradigm

  2011cites this paper
• The Role of Salt in the Pathogenesis of Fructose-Induced Hypertension

  2011cites this paper
• Hypertension in obesity.

  2011cites this paper
• Rola glikokortykosteroidów w etiologii nadciśnienia tętniczego Glucocorticoids action in etiology of hypertension

  2010cites this paper
• The mechanisms of the relationship between glucocorticoids and cardiovascular diseases.

  2010cites this paper
• Ocena wpływu składu diety i jej uzupełniania wybranymi składnikami mineralnymi na stężenie kortykosteronu i bilans wodny u samców szczura

  2009cites this paper
• Hypothalamic-Pituitary-Adrenal Axis Abnormalities in Response to Deletion of 11β-HSD1 is Strain-Dependent

  2009cites this paper
• Adipose tissue 11-beta-Hydroxysteroid Dehydrogenase Type 1 and Hexose-6-Phosphate Dehydrogenase gene expressions are increased in patients with type 2 diabetes mellitus.

  2008cites this paper
• Il tessuto adiposo come organo multifunzionale

  2008cites this paper
• The role of 11beta-hydroxysteroid dehydrogenase in metabolic disease and therapeutic potential of 11beta-hsd1 inhibitors.

  2008cites this paper
• Hypertension in obesity.

  2008cites this paper
• Association between the metabolic syndrome and serum cortisol in overweight Latino youth.

  2008cites this paper
• Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death.

  2007cites this paper
• Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.

  2007cites this paper
• Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devices.

  2007cites this paper
• Key reports from the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV 2007

  2007cites this paper
• and onset of obesity

  2007cites this paper
• Should aldosterone antagonists be considered as primary therapy for prevention of sudden cardiac death? Added Benefit of Mineralocorticoid Receptor Blockade in the Primary Prevention of Sudden Cardiac Death C ONTROVERSIES IN C ARDIOVASCULAR M EDICINE

  2007cites this paper
• Вплив кортизолу на порушення сну

  year unknowncites this paper